Location
United States, North America
Cheque size
$50K - $150M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Consumer Health
AgTech
Pharmaceuticals
About Investor
Kristina Burow is Managing Director at ARCH Venture Partners. Her investment focus is the creation and development of biotech, pharmaceutical, and health tech companies, typically spanning Seed and Series A (and beyond, based on her recorded activity). Her investment range is $50K – $150.0M. She joined ARCH in 2002 and has progressed from associate to managing director while helping build out ARCH’s life sciences portfolio.
Previous investments
Tenvie Therapeutics
200M |2025
Metsera
220M |2024
290M |2024
Autobahn Therapeutics
100M |2024
76M |2020
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.